Literature DB >> 12814762

Cross-cultural adaptation and validation of an Arabic Health Assessment Questionnaire for use in rheumatoid arthritis patients.

Yasser M El Meidany1, Maha M El Gaafary, Ihab Ahmed.   

Abstract

OBJECTIVE: To test the reliability and validity of a modified and translated version of the original Health Assessment Questionnaire (HAQ) on patients with rheumatoid arthritis (RA).
METHOD: A cohort of 184 RA patients from different Arabic countries (Egypt, Saudi Arabia, Sudan, Syria, Bahrain, Kuwait and Morocco) were recruited and asked to participate in the study. Two questions had been changed to suit the Arabic culture and to tackle some aspects that are commoner to be performed in the Arabic culture. After modification, translation and retranslation of the questionnaire, it was administered to the selected patients and tested for internal consistency, reliability and construct validity by correlating the yield of the questionnaire with other disease activity parameters. The questionnaire was administered again after a 1-week interval for evaluation of the reliability of this test. The modified questions were tested for their loyalty to the principal component and comparing their correlation with that of the other unchanged items.
RESULTS: Test-retest showed strong reliability with a high percentage of agreement and high values for Kappa. Internal consistency showed a high value for standardized alpha (Cronbach's): 0.979 that did not show any significant change if any of the 20 items had been eliminated. The modified questionnaire had shown a strong validity when correlating its results with other disease activity parameters. This correlation was the strongest with tender joint count (TJC), Ritchie articular index (RAI), morning stiffness (MS) and visual analogue scale (VAS) and the least (but still significant) with rheumatoid factor (RF).
CONCLUSION: The Arabic HAQ is a reliable and valid instrument that can be self-administered to Arabic RA patients to evaluate their functional disability. Its measurement properties were comparable to versions in other languages.

Entities:  

Mesh:

Year:  2003        PMID: 12814762     DOI: 10.1016/s1297-319x(03)00004-6

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  17 in total

1.  Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis.

Authors:  Samira Rostom; Karima Benbouaaza; Bouchra Amine; Rachid Bahiri; Yousra Ibn Yacoub; Sanae Ali Ou Alla; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

2.  Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients.

Authors:  Jason C Cole; Dinesh Khanna; Philip J Clements; James R Seibold; Donald P Tashkin; Harold E Paulus; Michael R Irwin; Sarosh J Motivala; Daniel E Furst
Journal:  Qual Life Res       Date:  2006-07-07       Impact factor: 4.147

3.  The validity and reliability of the Moroccan version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Najlaa Srifi; Rachid Bahiri; Samira Rostom; Imad Bendeddouche; Noufissa Lazrek; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2013-01       Impact factor: 2.631

4.  Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Authors:  Jennifer Petkovic; Jennifer L Barton; Caroline Flurey; Niti Goel; Christie M Bartels; Cheryl Barnabe; Maarten P T de Wit; Anne Lyddiatt; Diane Lacaille; Vivian Welch; Annelies Boonen; Beverley Shea; Robin Christensen; Lara J Maxwell; Willemina Campbell; Janet Jull; Karine Toupin-April; Jasvinder A Singh; Charles H Goldsmith; Antoine G Sreih; Christoph Pohl; Catherine Hofstetter; Dorcas E Beaton; Rachelle Buchbinder; Francis Guillemin; Peter S Tugwell
Journal:  J Rheumatol       Date:  2017-02-15       Impact factor: 4.666

5.  Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis.

Authors:  Nada Mahmoud Shresher; Aly Elsayed Mohamed; Mohsen Hassan Elshahaly
Journal:  Rheumatol Int       Date:  2019-08-03       Impact factor: 2.631

6.  Validation of an adapted arabic version of fibromyalgia syndrome impact questionnaire.

Authors:  Mai Abd El-Naby; Mohamed Ahmed Hefny; Ayman Ekram Fahim; Magdy Ahmed Awadalla
Journal:  Rheumatol Int       Date:  2013-05-17       Impact factor: 2.631

7.  Psychometric evaluation of a Moroccan version of health assessment questionnaire for use in Moroccan patients with rheumatoid arthritis.

Authors:  Fatima Ezzahra Abourazzak; Karima Benbouazza; Bouchra Amine; Rachid Bahiri; Noufissa Lazrak; Fatiha Bzami; Imane Jroundi; Redouane Abouqal; Francis Guillemin; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2008-06-06       Impact factor: 2.631

8.  Bone mineral density changes in patients with recent-onset rheumatoid arthritis.

Authors:  Eman A Hafez; Howaida E Mansour; Sherin H Hamza; Sherine George Moftah; Takwa Badr Younes; Mona Ahmed Ismail
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2011-10-09

9.  Relationship between different anti-rheumatic drug therapies and complementary and alternative medicine in patients with rheumatoid arthritis: an interview based cross-sectional study.

Authors:  Haya M Almalag; Aseel M Almuhareb; Aya A Alsharafi; Tariq M Alhawassi; Ahmed A Alghamdi; Hussain Alarfaj; Mohammed A Omair; Bedor A Alomari; Maysoon S Alblowi; Hanan H Abouzaid; Abdurhman S Alarfaj
Journal:  Saudi Pharm J       Date:  2021-04-23       Impact factor: 4.330

10.  Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis.

Authors:  Mohammed A Omair; Fatima Al Suwayeh; Alanoud Almashaan; Eman Alqurtas; Mohammed K Bedaiwi; Ibrahim Almaghlouth; Abdulaziz Alkahalaf; Haya M Almalaq
Journal:  Patient Prefer Adherence       Date:  2021-06-28       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.